ArticlePharmaceuticals (Basel, Switzerland)2026

Theranostic vNAR-Based Immunoconjugates Achieve Selective Intracellular Cisplatin Delivery in Embedded 3D HER2-Positive Breast Cancer In Vitro Model.

Andrea C Alfonseca-Ladrón de Guevara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.